Print this page
Personalized Oncology Promoting Equity for Black Lives (PROPEL)
The specific aims of this study are: 1) Test the efficacy of a culturally tailored and interactive electronic relational agent (RA) intervention vs. enhanced usual care (EUC) consisting of clinical letter and genetic recommendation on engagement in genetic education and genetic testing uptake; 2) Evaluate the impact of the RA vs. EUC on informed decision-making and psychosocial outcomes; and 3) Explore potential mechanisms by assessing mediators and moderations of efficacy.
Protocol Number:
132309
Phase:
N/A
Applicable Disease Sites:
Corpus Uteri
Prostate
Pancreas
Breast
Ovary
Colon
Prostate
Pancreas
Breast
Ovary
Colon
Principal Investigator:
Anita Kinney PhD,RN
Scope:
National
Participating Institutions:
- Rutgers Cancer Institute of New Jersey
- RWJBarnabas Health
- Community Medical Center
- Clara Maass Medical Center
- Cooperman Barnabas, Livingston
- Jersey City Medical Center, Jersey City
- Monmouth Medical Center
- Monmouth Medical Center Southern Campus
- Newark Beth Israel Medical Center
- Robert Wood Johnson University Hospital, Hamilton
- Robert Wood Johnson University Hospital, New Brunswick
- Robert Wood Johnson University Hospital, Rahway
- Robert Wood Johnson University Hospital, Somerset
- Trinitas Hospital and Comprehensive Cancer Center
- Rutgers Cancer Institute of New Jersey-University Hospital
For further information about clinical trials, please contact us at 732-235-7356.